Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Safety and Regenerative Properties of Immortalized Human Mesenchymal Stromal Cell Secretome
Maxim Karagyaur1, Alexandra Primak1, Nataliya Basalova1
1Medical Research and Education Institute, Lomonosov Moscow State University, 27/1, Lomonosovsky Ave., 119192 Moscow, Russia.
Abstract:
The secretome of mesenchymal stromal cells (MSCs) can efficiently stimulate regeneration and therefore is a tempting remedy for "cell-free cellular therapy". However, the usage of primary MSC cultures as secretome producers for translation studies has obvious obstacles, including the rapid aging of MSC cultures, the need for a large number of verified donors, and donor-to-donor variability of secretome content. MSCs immortalization makes it possible to overcome those limitations and to obtain secretome-producing cultures with a prolonged lifetime. However, the efficacy and safety of such secretomes are critical issues that limit their usage as therapeutic agents. In this study, we tested in large detail how the immortalization of MSC cultures affects the content, biological activity and safety of their secretome. MSCs immortalization via the overexpression of human TERT gene does not significantly alter the qualitative and quantitative composition of their secretome or its activity according to the results of proteomic analysis, ELISA, qPCR and functional tests in vitro. Moreover, we have demonstrated that the secretome of immortalized MSCs does not contain detectable amounts of telomerase and does not possess any transforming activity. Altogether, our data suggest that immortalized MSC cultures may become a reliable source for obtaining standardized active secretome in large-scale quantities for clinical use.

